entertainment -WSS

entertainment

author：explore 2025-08-11 07:58:34 - browse：9

What makes a blockbuster? Can biotech learn from Aduhelm? And how do you replace a singular regulator?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We explain the debate over Vertex Pharmaceuticals’ novel pain drug, whose success in clinical trials comes with a sizable caveat. We also talk about the latest news in the life sciences, including an epitaph for Aduhelm and the retirement of an FDA icon.

For more on what we cover, here’s the news on Vertex; here’s more on Aduhelm; here’s the exit interview with Janet Woodcock; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： In utero gene editing: an explainer

WSS

CEOs share strategies for surviving biotech slump

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

A solution to the after

Dario to buy mental health app maker Twill in cash and stock deal

Alabama IVF ruling threatens families facing fatal genetic disease

Obesity drugs seen as possible treatment for liver disease MASH

focus

entertainment

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Psychedelics group wrestles with new pharma identity

He's a Nobel laureate. Critics say he was misleading on Covid

Hepatitis C has a cure — but many Americans still lack access to it

He's a Nobel laureate. Critics say he was misleading on Covid

Anesthesiologist group: stop taking Ozempic before surgery

Alabama IVF ruling threatens families facing fatal genetic disease

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

hotspot

2023 STAT Wunderkinds: get to know the winners

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Why health workers in Gaza are injured or die at high rates

Solve the antibiotic resistance crisis with preventive drugs

UnitedHealth’s board chair also owns a personal investment firm

hotspot

leisure time

Wikipedia

Wikipedia